Stock Information
Agios Pharmaceuticals Inc (AGIO)
Ticker Symbol: AGIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,762.83 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -7.1183
Revenue (TTM): $0.93 M
Dividend Yield: N/A%
ROE: -31.07%
Latest News
-
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Tue, Mar 31, 2026 9:57 AM
-
Agios Pharmaceuticals shares are trading higher after the company announced that it will pursue accelerated FDA approval for mitapivat, an oral pyruvate kinase activator in sickle cell disease, following completion of its pre-supplemental New Drug Application (sNDA) meeting.
Tue, Mar 31, 2026 9:01 AM
-
Agios Pharmaceuticals Says It Will Pursue US Accelerated Approval For Mitapivat For Sickle Cell Disease
Tue, Mar 31, 2026 7:05 AM
Key Financials
Financial data not available
